Evelyn Partners Asset Management Ltd Acquires 10,038 Shares of CME Group Inc. $CME

Evelyn Partners Asset Management Ltd lifted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 70.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,189 shares of the financial services provider’s stock after purchasing an additional 10,038 shares during the quarter. CME Group accounts for 1.5% of Evelyn Partners Asset Management Ltd’s holdings, making the stock its 24th largest position. Evelyn Partners Asset Management Ltd’s holdings in CME Group were worth $6,606,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Evelyn Partners Investment Management Europe Ltd raised its position in shares of CME Group by 457.1% in the fourth quarter. Evelyn Partners Investment Management Europe Ltd now owns 195 shares of the financial services provider’s stock valued at $53,000 after buying an additional 160 shares in the last quarter. Aigen Investment Management LP acquired a new stake in shares of CME Group in the fourth quarter valued at approximately $351,000. Arrowstreet Capital Limited Partnership raised its position in shares of CME Group by 7.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,074,773 shares of the financial services provider’s stock valued at $839,659,000 after buying an additional 208,318 shares in the last quarter. Arete Wealth Advisors LLC raised its holdings in CME Group by 3.7% in the 4th quarter. Arete Wealth Advisors LLC now owns 5,305 shares of the financial services provider’s stock valued at $1,449,000 after acquiring an additional 190 shares in the last quarter. Finally, CreativeOne Wealth LLC lifted its position in shares of CME Group by 2.8% during the 4th quarter. CreativeOne Wealth LLC now owns 9,926 shares of the financial services provider’s stock valued at $2,711,000 after acquiring an additional 269 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Performance

NASDAQ:CME opened at $269.53 on Friday. The stock has a fifty day moving average price of $284.79 and a 200-day moving average price of $288.07. The company has a market cap of $97.67 billion, a price-to-earnings ratio of 23.00, a PEG ratio of 3.01 and a beta of 0.21. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the previous year, the firm earned $2.80 EPS. CME Group’s revenue was up 14.5% on a year-over-year basis. As a group, equities analysts anticipate that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is 44.37%.

Insider Transactions at CME Group

In other news, insider Hilda Harris Piell sold 5,753 shares of the business’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. The trade was a 17.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the business’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at $16,606,111.30. This trade represents a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 44,044 shares of company stock valued at $13,297,507. Corporate insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on CME shares. Weiss Ratings reiterated a “buy (a-)” rating on shares of CME Group in a research report on Friday, May 29th. Wall Street Zen upgraded CME Group from a “sell” rating to a “hold” rating in a research report on Saturday. Piper Sandler upped their target price on CME Group from $313.00 to $329.00 and gave the company an “overweight” rating in a research report on Wednesday, April 15th. Jefferies Financial Group cut their target price on CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $305.71.

Read Our Latest Stock Report on CME

CME Group News Summary

Here are the key news stories impacting CME Group this week:

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.